Search research articles
Contact Us
Filters
Showing results (381-390 of 421) with videos related to
Page
of 43
Sort By:
Cancer Research
|
July 7, 2025
Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor-Stroma Ratio and Promote Cancer Progression
Xin Lou, Yihua Shi, Faming Zhao, et al.
Nature Communications
|
May 28, 2026
Metabolic characterization of the tumor microenvironment orchestrates therapeutic strategies and clinical outcomes in pancreatic cancer
Rong Tang, Yangyi Li, Cong Zhou, et al.
Cancer Research
|
August 13, 2021
MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting <i>De Novo</i> Purine Synthesis and Glycolysis in Pancreatic Cancer
Qiangsheng Hu, Yi Qin, Shunrong Ji, et al.
International Journal of Surgery (London, England)
|
July 2, 2024
Tibial cortex transverse transport surgery improves wound healing in patients with severe type 2 DFUs by activating a systemic immune response: a cross-sectional study
Lin Yu, Dingwei Zhang, Yuan Yin, et al.
BMJ Open
|
July 6, 2026
Laparoscopic versus open pancreaticoduodenectomy for non-pancreatic periampullary adenocarcinomas: study protocol for a multicentre randomised controlled trial in China
Shizhen Li, Shutao Pan, Min Wang, et al.
Cancer Letters
|
March 5, 2026
Targeting ACSS2 Disrupts Metabolic-Epigenetic Crosstalk to Restore Apoptosis and Temozolomide Chemosensitivity in Pancreatic Neuroendocrine Tumors
Qin Dang, Liangju Peng, Yinrong Niu, et al.
Biomaterials
|
December 24, 2021
Exosomes derived from immunogenically dying tumor cells as a versatile tool for vaccination against pancreatic cancer
Wenxi Zhou, Xinli Chen, Yu Zhou, et al.
International Journal of Oncology
|
March 29, 2017
A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism
Wensheng Liu, Bo Zhang, Qiangsheng Hu, et al.
Cancers
|
August 7, 2021
Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21
Xuan Lin, Longyun Ye, Xu Wang, et al.
Cell Reports. Medicine
|
September 20, 2025
A phase 1 trial of APG-1387, an IAP antagonist, with nab-paclitaxel and gemcitabine in patients with refractory metastatic pancreatic cancer
Si Shi, Jian Zhang, Rujiao Liu, et al.
Page
of 43
Search research articles
Search
Showing results (381-390 of 421) with videos related to
Sort By:
Page
of 43
Cancer Research
|
July 7, 2025
Pancreatic Neuroendocrine Tumors Secrete Apolipoprotein E to Induce Tip Endothelial Cells That Remodel the Tumor-Stroma Ratio and Promote Cancer Progression
Xin Lou, Yihua Shi, Faming Zhao, et al.
Nature Communications
|
May 28, 2026
Metabolic characterization of the tumor microenvironment orchestrates therapeutic strategies and clinical outcomes in pancreatic cancer
Rong Tang, Yangyi Li, Cong Zhou, et al.
Cancer Research
|
August 13, 2021
MTAP Deficiency-Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting <i>De Novo</i> Purine Synthesis and Glycolysis in Pancreatic Cancer
Qiangsheng Hu, Yi Qin, Shunrong Ji, et al.
International Journal of Surgery (London, England)
|
July 2, 2024
Tibial cortex transverse transport surgery improves wound healing in patients with severe type 2 DFUs by activating a systemic immune response: a cross-sectional study
Lin Yu, Dingwei Zhang, Yuan Yin, et al.
BMJ Open
|
July 6, 2026
Laparoscopic versus open pancreaticoduodenectomy for non-pancreatic periampullary adenocarcinomas: study protocol for a multicentre randomised controlled trial in China
Shizhen Li, Shutao Pan, Min Wang, et al.
Cancer Letters
|
March 5, 2026
Targeting ACSS2 Disrupts Metabolic-Epigenetic Crosstalk to Restore Apoptosis and Temozolomide Chemosensitivity in Pancreatic Neuroendocrine Tumors
Qin Dang, Liangju Peng, Yinrong Niu, et al.
Biomaterials
|
December 24, 2021
Exosomes derived from immunogenically dying tumor cells as a versatile tool for vaccination against pancreatic cancer
Wenxi Zhou, Xinli Chen, Yu Zhou, et al.
International Journal of Oncology
|
March 29, 2017
A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism
Wensheng Liu, Bo Zhang, Qiangsheng Hu, et al.
Cancers
|
August 7, 2021
Follicular Helper T Cells Remodel the Immune Microenvironment of Pancreatic Cancer via Secreting CXCL13 and IL-21
Xuan Lin, Longyun Ye, Xu Wang, et al.
Cell Reports. Medicine
|
September 20, 2025
A phase 1 trial of APG-1387, an IAP antagonist, with nab-paclitaxel and gemcitabine in patients with refractory metastatic pancreatic cancer
Si Shi, Jian Zhang, Rujiao Liu, et al.
Page
of 43